HUMIRA® (adalimumab) Pen
- Product Description
The HUMIRA® Pen is a single use, disposable delivery system for administering HUMIRA® (adalimumab), an FDA approved treatment for moderate to severe rheumatoid arthritis (RA) and psoriatic arthritis (PsA) created by Abbott. With its one-touch activation and easy-to-grip size and shape, the HUMIRA® Pen offers improved ease of use for these patients, many of whom may have swelling or stiffness in the hands.
The HUMIRA® Pen is a single-use pen containing a 1 mL prefilled glass syringe with a fixed 27 gauge 1/2 inch needle, providing 40 mg (0.8 mL) of HUMIRA. Talk with your doctor about the HUMIRA® Pen and the HUMIRA® prefilled syringe.